H. Lee Moffitt Cancer Center and Research Institute, Inc — Tampa, Florida

Public research footprint of H. Lee Moffitt Cancer Center and Research Institute, Inc, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET… · Squamous Cell Carcinoma of Head and Neck · Breast Cancer · Colorectal Cancer

Recently updated registry entries

NCT02718066 — Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell… (Completed)
NCT02864992 — Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) (Active Not Recruiting)
NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at H. Lee Moffitt Cancer Center and Research Institute, Inc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.